Nicholas Michael Mordwinkin - Aug 1, 2022 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
Chief Business Officer
Signature
/s/ Marc Belsky, Attorney-in-Fact
Stock symbol
KZR
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
4
Date filed
8/2/2022, 04:47 PM
Previous filing
Jul 15, 2022
Next filing
Jan 10, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KZR Employee Stock Option (right to buy) Award $0 +200K $0.00 200K Aug 1, 2022 Common Stock 200K $9.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date.